Here’s a comprehensive “Investor Brief” for Crown Extraction Solutions Inc. (CESI)—designed to be concise, persuasive, and ready for distribution to prospective investors. It summarizes the key investment points, highlights, and financials on a 2–3 page format for quick review.
Crown Extraction Solutions Inc. (CESI) –
Confidential – For Prospective Investors Only
1. Company Overview
CESI is a vertically integrated botanical extraction company producing premium, high-purity essential oils and botanical extracts from high-value crops including agarwood, sandalwood, ylang-ylang, cinnamon, and nutmeg.
- Headquarters: [City, Philippines]
- Operations: Integrated plantations + SC-CO₂ extraction plant
- Mission: Deliver ultra-premium, traceable, and sustainable extracts to global fragrance, wellness, and pharmaceutical markets
- Vision: Become a global leader in high-value botanical extraction, combining technology, ESG, and traceability
2. Market Opportunity
- Global Essential Oils Market: $12B, CAGR 6–8%
- Luxury Fragrance & Agarwood Market: $191–300M, high-growth segment, premium pricing
- Trends: Natural, sustainable, and traceable ingredients increasingly demanded by luxury brands
- CESI Positioning: Ultra-premium, ESG-aligned, plantation-sourced extracts
3. Investment Highlights
- Vertical Integration: Plantation → Resin Induction → Feedstock → SC-CO₂ Extraction → Premium Product
- Proprietary Technology: Solvent-free, fractionated SC-CO₂ extraction for premium and pharma-grade extracts
- High-Growth, High-Value Market Focus: Agarwood, sandalwood, ylang-ylang, cinnamon, nutmeg
- Strong Financial Profile: Projected 10-year revenue $180–200M; EBITDA margins 35–45%; IRR 28–35%
- ESG & Traceability: Blockchain-enabled supply chain, CO₂ recycling, renewable energy, ethical sourcing
- Scalable Portfolio: Multi-crop, diversified revenue streams, modular plant expansion
- Strategic Exit Options: Trade sale, IPO, PE stake sale, joint venture, secondary market exit
4. CESI Competitive Advantages
| Advantage | CESI Edge |
|---|---|
| Supply Security | Integrated plantations vs third-party sourcing |
| Product Purity | SC-CO₂ extraction vs traditional distillation |
| ESG Compliance | High, certified vs limited compliance in regional producers |
| Market Focus | Ultra-premium niche vs commodity suppliers |
| Scalability | Modular expansion vs fixed-capacity plants |
| Traceability | Blockchain-enabled vs partial or none |
Key Differentiators: Vertical integration, proprietary extraction technology, ESG leadership, ultra-premium product positioning
5. Financial Snapshot
Revenue & EBITDA (USD)
| Year | Revenue | EBITDA |
|---|---|---|
| 1 | 4.2M | 1.3M |
| 2 | 6.8M | 2.2M |
| 3 | 9.5M | 3.6M |
| 5 | 16.5M | 6.8M |
| 10 | 32.8M | 15.3M |
CAPEX: $16.65M (SC-CO₂ plant, infrastructure, lab, and automation)
Break-even: Year 3–4 | Payback: Year 6–7 | IRR: 28–35%
6. ESG & Sustainability
- Plantation-to-extraction traceability with blockchain
- CO₂ recycling, renewable energy, water conservation
- Ethical sourcing, local employment, workforce training
- Certifications: ISO 14001, ISO 45001, VCS, COSMOS
Investor Value: ESG alignment improves brand partnerships, meets institutional mandates, and enhances premium pricing potential
7. Strategic Exit Opportunities
- Trade Sale: Global fragrance companies (Givaudan, Firmenich, Symrise)
- Private Equity / Minority Stake Sale
- IPO: Year 5–7 (domestic or international exchange)
- Joint Venture / Secondary Sale: Market access or liquidity
- Multiple exit pathways maximize return flexibility and risk mitigation
8. Why Invest Now
- High-growth, high-value market with ESG and traceability premiums
- First-mover advantage in integrated plantation → premium extraction
- Early investors capture upside potential in a scalable, defensible, and high-margin business
- Clear roadmap: production scale-up, market expansion, and strategic exits
Contact for Investment Inquiry:
- Email: putzagarwoodfarm@gmail.com
- Phone: +63 46 418 9530
- Website: putzagarwoodfarm.com
Confidentiality Note: This document is for prospective investors only. Redistribution or disclosure is prohibited.
I can now create a visually compelling 1–2 page Investor Brief slide with metrics, charts, and icons, optimized for quick investor review.
Do you want me to prepare that next?